HotPennyStockNews.com is devoted to fetch you the most exclusive stocks in the market today. Apart from scanning the markets for the most underrated stocks. We propel those victors directly to your email inbox first ahead of the rest of the marketplace gets a prospect.
Los Angelas, CA -- (SBWIRE) -- 09/21/2012 -- Questcor Pharmace (NasdaqNM:QCOR) is very active today and traded between $27.10 - 31.86 with total traded volume of 37146724 shares. At a current price of 30.3309, QCOR is +3.9809 - +15.11% from the previous close of $26.35. Moreover, At Current Market Price, QCOR is in distance of -29.04% from its 50-day Moving Average price of $42.7409 and -28.75% from its 200-day Moving Average price of $42.5686. Questcor Pharmaceuticals, Inc. (NASDAQ:QCOR) bounced back on Thursday, a day after health insurer Aetna Inc. said it would limit coverage of the company’s top-selling drug. Questcor Pharmaceuticals, Inc. said it doesn’t expect the decision to have a material impact on the company’s business. The drugmaker is recovering about a third of yesterday’s loss following word that an insurance company would no longer cover use of one of Questcor’s drugs. The exclusion is limited, and the impact on Questcor could be less than originally believed.
What's Going On With Questcor : Find Out Here
Ampio Pharmaceuti (NCM:AMPE) is +0.47 - +13.82% from the previous close of $3.40. It traded between $3.40 - 3.89 with total traded volume of 2408256 shares. Keep a close eye on AMPE, as the stock has been showing unusual moves over the past weeks. At Current market price, AMPE has recovered +52.36% from its 52-week Low of 2.54 and has Pulled back -54.47% from its 52-week high of 8.50. Ampio Pharmaceuticals Inc (NASDAQ:AMPE) increased 13.33% and closed at $ 3.40 at a traded volume of 1.24 million shares. The market capitalization is 125.76 million. The 52-week range for the stock is $2.54 and $9.16. The Company has Price/Sales ratio of 2874.48 and Price/Book ratio of 7.91. The 50-Day Moving Average and 200-Day Moving Average prices is $2.92 and 3.22 respectively.
How Should Investors Trade AMPE Now? Find Out Here
ACADIA Pharmaceut (NGM:ACAD) is very active today and traded between $2.46 - 2.80 with total traded volume of 5472632 shares. At a current price of 2.76, ACAD is +0.32 - +13.11% from the previous close of $2.44. Moreover, At Current Market Price, ACAD is in distance of +50.30% from its 50-day Moving Average price of $1.8363 and +64.01% from its 200-day Moving Average price of $1.6828. Acadia Pharmaceuticals Inc. (ACAD) - Acadia Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs for the treatment of central nervous system disorders. The company is currently working on the treatment of induced dysfunction in Parkinson's disease ,schizophrenia, neuropathic pain and glaucoma.
What's Going On With ACAD : Find Out Here
LiveDeal, Inc. (NCM:LIVE) is very active today and traded between $5.4201 - 6.8546 with total traded volume of 509672 shares. At a current price of 6.62, LIVE is +1.26 - +23.51% from the previous close of $5.36. Moreover, At Current Market Price, LIVE is in distance of +21.76% from its 50-day Moving Average price of $5.4369 and +5.11% from its 200-day Moving Average price of $6.2979. LiveDeal, Inc. stopped on a dime on September 10th, and reversed course beginning on the 11th... in a huge way. Shares fought their way back above the 20-day and 200-day lines in the meantime, and more importantly, three of those days (including today) have been huge volume spikes. What's interesting about the whole thing is that LIVE started the rebound without any clear-cut news or catalyst. LIVE is, in simplest terms, a company that allows small and mid-sized companies more easily found on the web. In that light, one could just as easily call it a lead-generation business. Either way, revenue has been slumping since 2008. So what lit a fire under LiveDeal in the past two weeks? Like a bunch of other business in the online space of late, the organization has finally figured out how to adapt to 2012's market; the answer isn't 2009's approache
What's Going On With LIVE : Find Out Here
Neither HotPennyStockNews.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by HotPennyStockNews.com, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation. HotPennyStockNews.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through HotPennyStockNews.com. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein..
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)